1. Samaranayake LP. Essential microbiology for dentistry. 3rd ed. New York: Churchill Livingstone Elsevier;2006.
2. Lynch AS, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med. 2008; 59:415–428.
Article
3. Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 2006; 6:979–986.
Article
4. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001; 183:5385–5394.
Article
5. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol. 2006; 9:340–345.
Article
6. Baillie GS, Douglas LJ. Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol. 1999; 48:671–679.
Article
7. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004; 17:255–267.
8. Hansen SK, Rainey PB, Haagensen JA, Molin S. Evolution of species interactions in a biofilm community. Nature. 2007; 445:533–536.
Article
9. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005; 43:5721–5732.
Article
10. Manson JM, Rauch M, Gilmore MS. The commensal microbiology of the gastrointestinal tract. Adv Exp Med Biol. 2008; 635:15–28.
Article
11. Mclean RJC, Banes MB, McGowin CL, Aron GM. Methods of studying biofilms. In : Ghannoum MA, O'Toole GA, editors. Microbial biofilms. Washington, DC: ASM Press;2004. p. 379–413.
12. Tolker-Nielsen T, Hansen SK. Microbial interaction in mixed-species biofilms. In : Ghannoum MA, O'Toole GA, editors. Microbial biofilms. Washington, DC: ASM Press;2004. p. 206–221.
13. Shirtliff ME, Peters BM, Jabra-Rizk MA. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett. 2009; 299:1–8.
14. Ramage G, Vandewalle K, Wickes BL, López-Ribot JL. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol. 2001; 18:163–170.
15. Thein ZM, Seneviratne CJ, Samaranayake YH, Samaranayake LP. Community lifestyle of Candida in mixed biofilms: a mini review. Mycoses. 2009; 52:467–475.
16. El-Azizi MA, Starks SE, Khardori N. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. J Appl Microbiol. 2004; 96:1067–1073.
Article
17. Uppuluri P, Dinakaran H, Thomas DP, Chaturvedi AK, Lopez-Ribot JL. Characteristics of Candida albicans biofilms grown in a synthetic urine medium. J Clin Microbiol. 2009; 47:4078–4083.
Article
18. Nailis H, Kucharíková S, Ricicová M, Van Dijck P, Deforce D, Nelis H, et al. Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression. BMC Microbiol. 2010; 10:114.
Article
19. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005; 28:1062–1068.
Article
20. Li X, Yan Z, Xu J. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology. 2003; 149(Pt 2):353–362.
Article
21. Hogan DA, Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science. 2002; 296:2229–2232.
Article
22. Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorum sensing molecule influences Candida albicans morphology. Mol Microbiol. 2004; 54:1212–1223.
Article
23. Bandara HM, Yau JY, Watt RM, Jin LJ, Samaranayake LP. Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation. J Med Microbiol. 2009; 58(Pt 12):1623–1631.
Article
24. Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999; 283:1535–1538.
Article
25. Hoyer LL. The ALS gene family of Candida albicans. Trends Microbiol. 2001; 9:176–180.
Article
26. Birse CE, Irwin MY, Fonzi WA, Sypherd PS. Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infect Immun. 1993; 61:3648–3655.
Article
27. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003; 67:400–428.
Article
28. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003; 67:400–428.
Article
29. Armbruster CE, Hodges SA, Mobley HL. Initiation of swarming motility by Proteus mirabilis occurs in response to specific cues present in urine and requires excess L-glutamine. J Bacteriol. 2013; 195:1305–1319.
Article